Apreo Health

Apreo Health

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://apreohealth.com/

Last Round

Corporate Funding

May 13, 2026

Total Funding Raised

$153M

Company Overview

Apreo Health is a medical device company developing a tissue-sparing treatment for severe emphysema.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

emphysema treatmentCOPD treatmentairway scaffoldmedical devicebronchoscopic implantCOPDinterventional pulmonologyminimally invasive procedurenitinol implanttissue-sparing therapycollateral ventilationlung hyperinflationairway stentFDA breakthrough deviceclinical stage medtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apreo Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Apreo Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 13, 2026
Series BAug 7, 2025

Key People

Founding team and executive leadership

Martin Mayse

Co-Founder, Chief Scientific Officer, Board Member

Founding Team

Patrick Wu

Chief Technology Officer

Executive Team

Edward Enyeart

Chief Financial Officer

Executive Team

Jonathan Porter

Chief Product Officer

Executive Team

Apreo Health Investors

Notable investors and investment history

InvestorRounds
Bain Capital Life SciencesSeries B
The FoundrySeries A
Lightstone VenturesSeries B, Series A
Santé VenturesSeries B, Series A
Norwest Venture PartnersSeries B
Intuitive VenturesSeries B
F-Prime CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    Completed a corporate funding round.

  • Aug 7, 2025

    $130M round led by Norwest Venture Partners and Bain Capital Life Sciences.

Apreo Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Apreo Health Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range987
Year Founded2021
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.